• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肺结核病史会加速慢性阻塞性肺疾病(COPD)的早期发病和严重程度:来自罗马尼亚一项多中心研究的证据。

History of Pulmonary Tuberculosis Accelerates Early Onset and Severity of COPD: Evidence from a Multicenter Study in Romania.

作者信息

Cioboata Ramona, Vlasceanu Silviu Gabriel, Mitroi Denisa Maria, Zlatian Ovidiu Mircea, Balteanu Mara Amalia, Andrei Gabriela Marina, Biciusca Viorel, Olteanu Mihai

机构信息

Department of Pneumology, University of Medicine and Pharmacy, 200349 Craiova, Romania.

Department of Pneumology, Victor Babes University Hospital, 200515 Craiova, Romania.

出版信息

J Clin Med. 2025 Aug 24;14(17):5980. doi: 10.3390/jcm14175980.

DOI:10.3390/jcm14175980
PMID:40943740
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12429621/
Abstract

Pulmonary tuberculosis (TB) is increasingly recognized as a risk factor for chronic obstructive pulmonary disease (COPD), but its impact on COPD onset and severity remains poorly characterized, particularly in low- and middle-income countries. This multicenter study aimed to assess the impact of prior pulmonary TB on COPD onset, severity, the timing of the first severe exacerbation, and progression among Romanian patients with and without a history of pulmonary TB. : This retrospective multicenter study included adults hospitalized for their first severe COPD exacerbation at two tertiary care centers in Romania between April 2020 and April 2025. Patients were grouped based on smoking status and prior TB history. Propensity score matching was used to control for confounding factors. Clinical characteristics, spirometry, and radiological TB patterns were analyzed comparatively between patients with prior TB and TB-naïve patients. : Among 403 COPD patients, those with prior TB had significantly earlier COPD onset (mean age 48.67 ± 6.42 vs. 65.61 ± 5.14 years in smokers, < 0.001) and shorter intervals to their first severe COPD exacerbation compared to patients without prior TB (6.35 ± 4.71 vs. 15.14 ± 6.93 years in smokers, < 0.001). COPD prevalence was higher among TB survivors compared to those without TB history, especially in smokers (OR = 5.73; 95% CI, 3.30-9.94, < 0.001), versus non-smokers (OR =2.23; 95% CI, 1.37-3.64, = 0.001). Radiological severity of TB lesions significantly influenced COPD prevalence among smokers (OR = 10.79, < 0.001). Prior pulmonary TB substantially accelerates COPD onset, exacerbation timing, and disease severity, particularly in smokers. This multicenter comparative study demonstrates that prior pulmonary TB significantly accelerates COPD onset, exacerbation timing, and disease severity, especially among smokers. Recognizing TB history as a significant COPD risk factor underscores the importance of targeted COPD screening and tailored management in populations with high TB prevalence.

摘要

肺结核(TB)日益被视为慢性阻塞性肺疾病(COPD)的一个风险因素,但其对COPD发病和严重程度的影响仍未得到充分描述,尤其是在低收入和中等收入国家。这项多中心研究旨在评估既往肺结核对罗马尼亚有和没有肺结核病史的患者中COPD发病、严重程度、首次严重加重的时间以及疾病进展的影响。:这项回顾性多中心研究纳入了2020年4月至2025年4月期间在罗马尼亚两个三级医疗中心因首次严重COPD加重而住院的成年人。患者根据吸烟状况和既往结核病史进行分组。倾向得分匹配用于控制混杂因素。对有既往结核病史的患者和未感染结核的患者的临床特征、肺功能检查和放射学结核模式进行了比较分析。:在403例COPD患者中,有既往结核病史的患者COPD发病明显更早(吸烟者中平均年龄为48.67±6.42岁,而无既往结核病史的患者为65.61±5.14岁,<0.001),与无既往结核病史的患者相比,首次严重COPD加重的间隔时间更短(吸烟者中为6.35±4.71年,而无既往结核病史的患者为15.14±6.93年,<0.001)。与无结核病史的患者相比,结核幸存者中COPD患病率更高,尤其是在吸烟者中(OR = 5.73;95%CI,3.30 - 9.94,<0.001),非吸烟者中(OR = 2.23;95%CI,1.37 - 3.64,= 0.001)。结核病变的放射学严重程度显著影响吸烟者中的COPD患病率(OR = 10.79,<0.001)。既往肺结核显著加速COPD发病、加重时间和疾病严重程度,尤其是在吸烟者中。这项多中心比较研究表明,既往肺结核显著加速COPD发病、加重时间和疾病严重程度,尤其是在吸烟者中。将结核病史视为COPD的一个重要风险因素凸显了在结核高流行人群中进行有针对性的COPD筛查和个性化管理的重要性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dbbe/12429621/5f595b06a171/jcm-14-05980-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dbbe/12429621/74dc647d1a9b/jcm-14-05980-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dbbe/12429621/5f595b06a171/jcm-14-05980-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dbbe/12429621/74dc647d1a9b/jcm-14-05980-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/dbbe/12429621/5f595b06a171/jcm-14-05980-g002.jpg

相似文献

1
History of Pulmonary Tuberculosis Accelerates Early Onset and Severity of COPD: Evidence from a Multicenter Study in Romania.肺结核病史会加速慢性阻塞性肺疾病(COPD)的早期发病和严重程度:来自罗马尼亚一项多中心研究的证据。
J Clin Med. 2025 Aug 24;14(17):5980. doi: 10.3390/jcm14175980.
2
Self-management interventions including action plans for exacerbations versus usual care in patients with chronic obstructive pulmonary disease.慢性阻塞性肺疾病患者自我管理干预措施(包括针对病情加重的行动计划)与常规护理的比较。
Cochrane Database Syst Rev. 2017 Aug 4;8(8):CD011682. doi: 10.1002/14651858.CD011682.pub2.
3
Action plans with brief patient education for exacerbations in chronic obstructive pulmonary disease.针对慢性阻塞性肺疾病急性加重的简短患者教育行动计划。
Cochrane Database Syst Rev. 2016 Dec 19;12(12):CD005074. doi: 10.1002/14651858.CD005074.pub4.
4
Prescription of Controlled Substances: Benefits and Risks管制药品的处方:益处与风险
5
Pulmonary rehabilitation following exacerbations of chronic obstructive pulmonary disease.慢性阻塞性肺疾病急性加重后的肺康复治疗。
Cochrane Database Syst Rev. 2016 Dec 8;12(12):CD005305. doi: 10.1002/14651858.CD005305.pub4.
6
Aclidinium bromide for stable chronic obstructive pulmonary disease.阿地溴铵用于稳定期慢性阻塞性肺疾病
Cochrane Database Syst Rev. 2014 Sep 19;2014(9):CD010509. doi: 10.1002/14651858.CD010509.pub2.
7
Immunostimulants versus placebo for preventing exacerbations in adults with chronic bronchitis or chronic obstructive pulmonary disease.免疫刺激剂与安慰剂在预防慢性支气管炎或慢性阻塞性肺疾病成人恶化中的比较。
Cochrane Database Syst Rev. 2022 Nov 14;11(11):CD013343. doi: 10.1002/14651858.CD013343.pub2.
8
Prophylactic antibiotics for adults with chronic obstructive pulmonary disease: a network meta-analysis.慢性阻塞性肺疾病成人患者的预防性抗生素治疗:一项网络荟萃分析。
Cochrane Database Syst Rev. 2021 Jan 15;1(1):CD013198. doi: 10.1002/14651858.CD013198.pub2.
9
Sputum colour charts to guide antibiotic self-treatment of acute exacerbation of chronic obstructive pulmonary disease: the Colour-COPD RCT.用于指导慢性阻塞性肺疾病急性加重期抗生素自我治疗的痰液颜色图表:Colour-COPD随机对照试验
Health Technol Assess. 2025 May;29(28):1-42. doi: 10.3310/KPFD5558.
10
Computer and mobile technology interventions for self-management in chronic obstructive pulmonary disease.用于慢性阻塞性肺疾病自我管理的计算机和移动技术干预措施。
Cochrane Database Syst Rev. 2017 May 23;5(5):CD011425. doi: 10.1002/14651858.CD011425.pub2.

本文引用的文献

1
Pathophysiology, clinical manifestation, and treatment of tuberculosis-associated chronic obstructive pulmonary disease: a narrative review.结核相关慢性阻塞性肺疾病的病理生理学、临床表现及治疗:一项叙述性综述
Ewha Med J. 2025 Apr;48(2):e24. doi: 10.12771/emj.2025.00059. Epub 2025 Mar 19.
2
Beyond Smoking: Emerging Drivers of COPD and Their Clinical Implications in Low- and Middle-Income Countries: A Narrative Review.超越吸烟:慢性阻塞性肺疾病的新兴驱动因素及其在低收入和中等收入国家的临床意义:一项叙述性综述
J Clin Med. 2025 Jun 30;14(13):4633. doi: 10.3390/jcm14134633.
3
Leptin and Insulin in COPD: Unveiling the Metabolic-Inflammatory Axis-A Narrative Review.
慢性阻塞性肺疾病中的瘦素与胰岛素:揭示代谢-炎症轴——一篇叙述性综述
J Clin Med. 2025 Apr 10;14(8):2611. doi: 10.3390/jcm14082611.
4
Development of chronic obstructive pulmonary disease after a tuberculosis episode in a large, population-based cohort from Eastern China.中国东部一个大型人群队列中结核病发作后慢性阻塞性肺疾病的发生情况
Int J Epidemiol. 2025 Feb 16;54(2). doi: 10.1093/ije/dyae174.
5
Hypercoagulability in Tuberculosis: Pathophysiological Mechanisms, Associated Risks, and Advances in Management-A Narrative Review.结核病中的高凝状态:病理生理机制、相关风险及管理进展——一篇叙述性综述
J Clin Med. 2025 Jan 24;14(3):762. doi: 10.3390/jcm14030762.
6
Propensity Score Matching: should we use it in designing observational studies?倾向得分匹配:我们应该在设计观察性研究时使用它吗?
BMC Med Res Methodol. 2025 Jan 29;25(1):25. doi: 10.1186/s12874-025-02481-w.
7
Impact of drug-resistant tuberculosis on socio-economic status, quality of life and psychological well-being of patients in Bucharest, Romania: a prospective cohort study.耐药结核病对罗马尼亚布加勒斯特患者社会经济状况、生活质量及心理健康的影响:一项前瞻性队列研究
J Health Popul Nutr. 2024 Dec 22;43(1):223. doi: 10.1186/s41043-024-00717-x.
8
Insights from the 2024 WHO Global Tuberculosis Report - More Comprehensive Action, Innovation, and Investments required for achieving WHO End TB goals.《2024年世界卫生组织全球结核病报告》见解——实现世界卫生组织终止结核病目标需要更全面的行动、创新和投资。
Int J Infect Dis. 2025 Jan;150:107325. doi: 10.1016/j.ijid.2024.107325. Epub 2024 Dec 2.
9
Under-Prescription of Drugs in the Elderly Population of Western Romania: An Analysis Based on STOPP/START Version 2 Criteria.罗马尼亚西部老年人群体药物处方不足:基于STOPP/START第2版标准的分析
J Clin Med. 2024 Oct 8;13(19):5970. doi: 10.3390/jcm13195970.
10
The Clinical Characteristics, Treatment and Prognosis of Tuberculosis-Associated Chronic Obstructive Pulmonary Disease: A Protocol for a Multicenter Prospective Cohort Study in China.肺结核相关性慢性阻塞性肺疾病的临床特征、治疗及预后:一项中国多中心前瞻性队列研究方案
Int J Chron Obstruct Pulmon Dis. 2024 Sep 25;19:2097-2107. doi: 10.2147/COPD.S475451. eCollection 2024.